HUENENBERG, Switzerland--(BUSINESS WIRE)--Alcon, Inc. (NYSE:ACL) reported that global sales rose 15.3 percent to $1.72 billion for the first quarter of 2010, or 9.6 percent excluding the impact of foreign exchange fluctuations and acquisitions. Revenue from acquisitions added 20 basis points to sales growth in the quarter. U.S. health care reform reduced sales by $5 million in the quarter.
